Learn more about recent news related to Age Related Macular Degeneration (ARMD) (AMD)
New Hope For Better Macular Degeneration Treatments (WebMD) – (2/22/21)
“A promising new method is a tiny, refillable drug reservoir that is surgically implanted in the eye, just under the eyelid. The device is filled with a concentrated version of an anti-VEGF drug and delivers it to the back of the eye over an extended period. Instead of an injection every six to eight weeks, patients might get a refill once or twice a year. Research shows that many people treated this way go 15 months between treatments. Also under investigation are gene therapies to enable the eyes to make their own anti-VEGF medicine, the academy noted.”
Age-related Macular Degeneration: Poised for a New Treatment Era. (American Academy of Ophthalmology) – (2/11/21)
SAN FRANCISCO – “For more than a decade, ophthalmologists have treated wet age-related macular degeneration (AMD) with eye injections given every month or two, and dry AMD with antioxidant vitamins. These treatments were groundbreaking when introduced, offering hope for the first time that this sight-threatening disease could be slowed, and in some cases stopped or even reversed. As we mark February as AMD Awareness Month, the American Academy of Ophthalmology is highlighting what the next decade may hold for the 11 million Americans suffering from AMD.”
LIVING LIFE FULLY WITH MACULAR DEGENERATION 